Volume 54; Issue 6

Cancer Immunology, Immunotherapy

Volume 54; Issue 6

1

What is needed for effective antitumor immunotherapy? Lessons learned usingListeria monocytogenesas a live vector for HPV-associated tumors

S. Farzana Hussain, Yvonne Paterson

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 461 KB

english, 2005

2

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Volker Schirrmacher

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 367 KB

english, 2005

3

New developments in dendritic cell–based vaccinations: RNA translated into clinics

Frank Grünebach, Martin R. Müller, Peter Brossart

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 248 KB

english, 2005

4

Prevention of de novo prostate cancer by immunization with tumor-derived vaccines

Mark A. Suckow, William R. Wolter, Morris Pollard

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 350 KB

english, 2005

5

T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody

Szilvia Mosolits, Katja Markovic, Jan Fagerberg, Jan-Erik Frödin, Mohammad-Reza Rezvany, Shahryar Kiaii, Håkan Mellstedt, Mahmood Jeddi-Tehrani

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 462 KB

english, 2005

6

Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice

Robert J. Melder, Blaire L. Osborn, Todd Riccobene, Palanisamy Kanakaraj, Ping Wei, Guoxian Chen, David Stolow, Wendy Green Halpern, Thi-Sau Migone, Qi Wang, Krzysztof J. Grzegorzewski, Gilles Gallant

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 649 KB

english, 2005

7

Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma

David A. Rodeberg, Rebecca A. Nuss, Carrie J. Heppelmann, Esteban Celis

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 327 KB

english, 2005

8

Secretomers as a new tool for the monitoring of CTL responses

Bastien Calmels, Stephane Paul, Christelle Ziller, Bruce Acres

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 571 KB

english, 2005

9

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario

Annalisa Astolfi, Simona Rolla, Patrizia Nanni, Elena Quaglino, Carla De Giovanni, Manuela Iezzi, Piero Musiani, Guido Forni, Pier-Luigi Lollini, Federica Cavallo, Raffaele A. Calogero

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 728 KB

english, 2005

10

Binding parameters of antibodies: pseudo-affinity and other misconceptions

M. Jules. Mattes

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 229 KB

english, 2005

11

Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma

Marc Brinkman, Juergen Walter, Swen Grein, Michael J. W. Thies, Torsten W. Schulz, Martin Herrmann, Christian O. A. Reiser, Juergen Hess

Journal:

Cancer Immunology, Immunotherapy

Année:

2005

Langue:

english

Fichier:

PDF, 405 KB

english, 2005